热门资讯> 正文

MacroGenics任命新首席执行官

2025-08-14 04:24

MacroGenics (NASDAQ:MGNX) has appointed Eric Risser as president, chief executive officer, and board member effective August 13, 2025.
Risser has served as the company's chief operating officer since 2022.
Risser succeeds Dr. Scott Koenig as CEO.
Source: Press release

More on MacroGenics

MacroGenics: Working On That Road To Recovery
MacroGenics signs financial deal with Sagard for retifanlimab
Seeking Alpha’s Quant Rating on MacroGenics
Historical earnings data for MacroGenics
Financial information for MacroGenics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。